Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

Nonmelanoma skin cancers (NMSCs) are some of the most commonly diagnosed malignancies. In general, early-stage NMSCs have favorable outcomes; however, a small subset of patients develop resistant, advanced, or metastatic disease, or aggressive subtypes that are more challenging to treat successfully...

Descripción completa

Detalles Bibliográficos
Autores principales: Silk, Ann W, Barker, Christopher A, Bhatia, Shailender, Bollin, Kathryn B, Chandra, Sunandana, Eroglu, Zeynep, Gastman, Brian R, Kendra, Kari L, Kluger, Harriet, Lipson, Evan J, Madden, Kathleen, Miller, David M, Nghiem, Paul, Pavlick, Anna C, Puzanov, Igor, Rabinowits, Guilherme, Ruiz, Emily S, Sondak, Vernon K, Tavss, Edward A, Tetzlaff, Michael T, Brownell, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341183/
https://www.ncbi.nlm.nih.gov/pubmed/35902131
http://dx.doi.org/10.1136/jitc-2021-004434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341183/
https://www.ncbi.nlm.nih.gov/pubmed/35902131
http://dx.doi.org/10.1136/jitc-2021-004434

Ejemplares similares